Medications

Genetic test maker 23andMe launches drug R&D effort

Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines.

Medical research

Pfizer, 23andMe team up to study bowel disease

Pfizer Inc. is teaming up with DNA testing company 23andMe to study the possible genetic underpinnings of inflammatory bowel disease, a hard-to-treat ailment that affects an estimated 1.4 million Americans.

page 3 from 4